Hetero acquires Johnson & Johnson's manufacturing plant in Telangana

"We are committed to an investment upwards of USD 75 million, (approximately Rs 600 crore) to upgrade and enhance existing facilities at the site and expand manufacturing of our global biologics and sterile pharmaceutical products," Hetero Managing Director Vamsi Krishna Bandi said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/5I9y8Qg
via IFTTT